Skip to main content
. 2021 Apr 6;5:PO.20.00119. doi: 10.1200/PO.20.00119

FIG 3.

FIG 3.

Survival outcomes of patients with stage I-IIA CM by 31-GEP results compared with stage IIB-III overall. RFS, DMFS, and OS were estimated by Kaplan-Meier analysis and P values determined by logrank test. Tables beneath the graphs show survival rates and number of events in each GEP class. CM, cutaneous melanoma; DMFS, distant metastasis-free survival; GEP, gene expression profile; OS, overall survival; RFS, recurrence-free survival.